Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.9900
-0.0220
(-1.09%)
At close: April 4 at 8:06:05 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-733,922
-733,922
-755,654
-502,733
-481,168
Investing Cash Flow
-116
-116
-284
229,313
-2,399
Financing Cash Flow
405,843
405,843
-7,545
1,117,681
-4,857
End Cash Position
405,280
405,280
732,060
1,496,179
651,342
Capital Expenditure
-116
-116
-284
-3,331
-2,399
Issuance of Capital Stock
354,308
354,308
--
396,196
--
Issuance of Debt
--
--
--
728,373
--
Free Cash Flow
-734,038
-734,038
-755,938
-506,064
-483,567
12/31/2021 - 7/10/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FARON.HE Faron Pharmaceuticals Oy
2.4300
-2.61%
AURA Aura Biosciences, Inc.
5.43
-4.90%
TECX Tectonic Therapeutic, Inc.
15.62
-6.30%
QTTB Q32 Bio Inc.
1.6400
+2.50%
UNCY Unicycive Therapeutics, Inc.
0.5159
-12.56%
TSHA Taysha Gene Therapies, Inc.
1.2200
-3.17%
OCUL Ocular Therapeutix, Inc.
6.36
-9.21%
RCKT Rocket Pharmaceuticals, Inc.
5.12
-7.91%
ALNY Alnylam Pharmaceuticals, Inc.
235.74
-10.08%
EWTX Edgewise Therapeutics, Inc.
11.51
-15.24%